• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Lycera to Present Clinical Results & Supporting Preclinical Data

    PRESS RELEASE

    Lycera Presents Clinical Safety & Selection Results RORgamma Agonist LYC-55716

    PRESS RELEASE

    Lycera to Present on First-in-class RORgamma Agonist Candidate LYC-55716

    Lycera Announces Publication of Preclinical Immuno-Oncology Research

    PRESS RELEASE

    Lycera Announces Initiation of Phase 1b LYC-55716 in Combination Pembrolizumab

    PRESS RELEASE

    Lycera Announces Advancement of Novel Immuno-Oncology Candidate LYC-55716

    PRESS RELEASE

    Lycera Announces Initiation of Phase 2 UPRISE Clinical Trial of LYC-30937-EC

    PRESS RELEASE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.